Welcome to China SXT Pharmaceuticals, Inc. Official Website!
Hotline:
+86-523-86299087
Email:
ir@sxtchina.com
NASDAQ:
SXTC
Contact Us
Toggle navigation
HOME
ABOUT
COMPANY
TEAM
COMPANY STRUCTURE
COMPANY AWARDS
CONTACT
BRAND
BRAND HISTORY
R&D
RESEARCH AND DEVELOPMENT
R&D STRATEGY
INTELLECTUAL PROPERTY RIGHT
MEDIA
LATEST NEWS
COMPANY NEWS
INVESTORS
STOCK INFO
SEC FILINGS
FINANCIALS
PRESS
SHAREHOLDER SERVICES
PUBLIC POLICIES
POLICIES
GUIDELINES
X
HOME
ABOUT
COMPANY
TEAM
COMPANY STRUCTURE
COMPANY AWARDS
CONTACT
BRAND
BRAND HISTORY
R&D TEAM
RESEARCH AND DEVELOPMENT
R&D STRATEGY
INTELLECTUAL PROPERTY RIGHT
PRODUCT
DIRECTLY-ORAL TCMP
AFTER-SOAKING-ORAL TCMP
FINE TCMP
REGULAR TCMP
MEDIA
LATEST NEWS
COMPANY NES
INVESTORS
STOCK INFO
SEC FILINGS
FINANCIALS
PRESS
SHAREHOLDER SERVICES
PUBLIC POLICIES
POLICIES
GUIDELINES
LATEST NEWS
2018-09-15: Research and Development of Innovative New Advanced TCMP
Last:
China SXT Pharmaceuticals, Inc. Announces Effectiveness of Registration Statement on Form F-1 and Pricing the Initial Public Offering of its Ordinary Shares at $4.00 per Share
Next:
Nasdaq’s Head of Healthcare Listings Shares 2018 Predictions for Biotech IPOs